Informations générales (source: ClinicalTrials.gov)

NCT03464344 En recrutement
COrtical Superficial Siderosis and REcurrent Lobar Intracerebral Hemorrhage in Cerebral Amyloid Angiopathy. (CORELIA)
Interventional
  • Amyloïdose
  • Hémorragie cérébrale
  • Hémorragie
  • Sidérose
  • Angiopathie amyloïde cérébrale
  • Angiopathie amyloïde cérébrale familiale
N/A
University Hospital, Toulouse (Voir sur ClinicalTrials)
octobre 2018
février 2025
28 août 2024
Cerebral amyloid angiopathy (CAA) is a major cause of lobar intracerebral hemorrhage (ICH) in the elderly with high risk of recurrence. The investigators aim to determine the relationship between cortical superficial siderosis (cSS), a MRI hemorrhagic marker of CAA and the risk of symptomatic ICH recurrence in a multicentric prospective cohort of patients with acute lobar ICH related to CAA. The investigators hypothesize that patients with cSS have an increased risk of recurrent symptomatic ICH relative to those without cSS.
 Voir le détail

Etablissements

Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
CHU Purpan. Hôpital Pierre-Paul Riquet - 31059 - Toulouse cedex 9 - France Nicolas RAPOSO, MD En recrutement Contact (sur clinicalTrials)
Gui de Chauliac Hospital - Montpellier - France Caroline ARQUIZAN Recrutement non commencé Contact (sur clinicalTrials)
Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
Lariboisière Hospital - Paris - France Eric JOUVENT En recrutement Contact (sur clinicalTrials)
Pellegrin Hospital - Bordeaux - France Igor SIBON En recrutement Contact (sur clinicalTrials)

Critères

Tous
Inclusion Criteria:

- Lobar ICH within 30 days after onset

- Available brain MRI sequences of adequate quality including fluid-attenuated
inversion recovery (FLAIR) and T2*-weighted gradient-recalled echo (T2*-GRE)
sequences.

- Modified Boston criteria for probable or possible CAA

- Age ≥ 55 years

- Written consent



- Secondary brain hemorrhage : vascular malformation (arteriovenous malformation,
aneurysm, cavernous); cerebral veinous thrombosis; brain tumor; coagulopathy;
vasculitis; hemorrhagic infarction,

- Infratentorial siderosis

- Contraindications to MRI

- Neurosurgical intervention before inclusion,

- Progressive neoplasm

- Patient without affiliation to the french social security

- Patient under guardianship